appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Thyrocare Technologies Ltd
THYROCARE
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Thyrocare Technologies Limited is a diagnostic chain company which offers a range of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.
PeersCompare with peers
Apollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Global Health Ltd
Dr. Lal PathLabs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
High Pledged Promoter HoldingLower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Thyrocare expands Northern India presence with Polo Labs acquisition
1 month ago•Business Standard
Thyrocare Q1 Results Review - Margin Thesis Is Starting To Unfold: ICICI Securities
1 month ago•Bloomberg Quint
Gainers & Losers: Dabur, Avanti Feeds among 9 stocks in limelight on Wednesday
1 month ago•Economic Times
Recent EventsAll events
Press Release
Thyrocare Technologies Limited has informed the Exchange regarding a press release dated August 30, 2024, titled "Thyrocare Technologies Limited enters into a Business Transfer Agreement to acquire diagnostic and pathological services business of Vimta Labs Limited.". | Download
Thyrocare Technologies Limited has informed the Exchange regarding a press release dated August 30, 2024, titled "Thyrocare Technologies Limited enters into a Business Transfer Agreement to acquire diagnostic and pathological services business of Vimta Labs Limited.". | Download
Shareholders meeting
Thyrocare Technologies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 23, 2024. Further, the company has informed the Exchange regarding voting results. | Download
Thyrocare Technologies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 23, 2024. Further, the company has informed the Exchange regarding voting results. | Download
Cash Dividend
Final • Div/Share: ₹ 18
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant